Słowa kluczowe
obesogeny
otyłość
substancje chemiczne
tkanka tłuszczowa
Jak cytować
Abstrakt
Współczesne społeczeństwo na co dzień zmaga się z problemem otyłości, która jest jednym z największych zagrożeń XXI wieku. Czynniki rozwoju otyłości są powszechnie znane, aczkolwiek jednym z mniej poznanych, ale równie ważnym czynnikiem jest ekspozycja na substancje chemiczne, nazywane obesogenami. Związki te znajdują się między innymi: w kosmetykach, żywności oraz tworzywach sztucznych, a narażenie może nastąpić poprzez skórę, drogi oddechowe oraz przewód pokarmowy. Wyniki wielu badań podkreślają konieczność zwiększenia kontroli i regulacji substancji chemicznych zawartych w produktach konsumenckich. Zrozumienie roli obesogenów, jako czynnika rozwoju otyłości, może pomóc w sformułowaniu lepszych i bardziej skutecznych strategii profilaktyki oraz leczenia, co ma kluczowe znaczenie dla zdrowia publicznego.
Bibliografia
Alharbi, H. F., Algonaiman, R., Alduwayghiri, R., Aljutaily, T., Algheshairy, R. M., Almutairi, A. S., Alharbi, R. M., Alfurayh, L. A., Alshahwan, A. A., Alsadun, A. F., & Barakat, H. (2022). Exposure to bisphenol A substitutes, bisphenol S and bisphenol F, and its association with developing obesity and diabetes mellitus: A narrative review. International Journal of Environmental Research and Public Health, 19(23), 15918. https://doi.org/10.3390/ijerph192315918
Amato, A. A., Wheeler, H. B., & Blumberg, B. (2021). Obesity and endocrine-disrupting chemicals. Endocrine Connections, 10(2), 87 – 105. https://doi.org/10.1530/EC-20-0578
Barra, G. N., Kwon, H. Y., Morrison, M. K., Steinberg, R. G., Wade, G. M., Khan, M. M., Schertzer, D. J., & Holloway, C. A. (2022). Increased gut serotonin production in response to bisphenol A structural analogs may contribute to their obesogenic effects. American Journal of Physiology – Endocrinology and Metabolism, 323(1), 80 – 91. https://doi.org/10.1152/ajpendo.00049.2022
Blüher, M. (2019). Obesity: Global epidemiology and pathogenesis. Nature Reviews Endocrinology, 15(5), 288 – 298. https://doi.org/10.1038/s41574-019-0176-8
Burki, T. (2021). European Commission classifies obesity as a chronic disease. The Lancet Diabetes & Endocrinology, 9(7), 418. https://doi.org/10.1016/S2213-8587(21)00145-0
Chamorro-García, R., & Veiga-Lopez, A. (2021). The new kids on the block: Emerging obesogens. Advances in Pharmacology, 92, 457 – 484. https://doi.org/10.1016/bs.apha.2021.05.003
Ćurić, M., Majanović, S. K., Detel, D., Ružić, A., & Štimac, D. (2021). Obesogens – new global health problem? Periodicum Biologorum, 123(3 – 4), 49 – 53. https://doi.org/10.18054/pb.v123i3-4.5032
Darbre, D. F. (2017). Endocrine disruptors and obesity. In Etiology of Obesity, 6(1), 18 – 27. https://doi.org/10.1007/s13679-017-0240-4
Egusquiza, R. J., & Blumberg, B. (2020). Environmental obesogens and their impact on susceptibility to obesity: New mechanisms and chemicals. Endocrinology, 161(3), Article bqaa024. https://doi.org/10.1210/endocr/bqaa024
Entezari, B., Bozdağ, D., & Orhan, H. G. (2022). Obesogens: Definition, mechanisms of action, potential industrial chemicals and pharmaceuticals. Istanbul Journal of Pharmacy, 52(2), 215 – 225. https://doi.org/10.26650/IstanbulJPharm.2022.102702
Folkvord, F., Naderer, B., Coates, A., & Boyland, E. (2021). Promoting fruit and vegetable consumption for childhood obesity prevention. Nutrients, 14(1), 157. https://doi.org/10.3390/nu14010157
Grün, F., & Blumberg, B. (2009a). Endocrine disrupters as obesogens. Molecular and Cellular Endocrinology, 304(1 – 2), 19 – 29. https://doi.org/10.1016/j.mce.2009.02.018
Grün, F., & Blumberg, B. (2009b). Minireview: The case for obesogens. Molecular Endocrinology, 23(8), 1127 – 1134. https://doi.org/10.1210/me.2008-0485
Grün, F., & Blumberg, N. (2006). Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling. Endocrinology, 147(6), 50 – 55. https://doi.org/10.1210/en.2005-1129
Gupta, R., Kumar, P., Fahmi, N., Garg, B., Dutta, S., Sachar, S., Mathaur, A. S., & Vimaleswaran, K. S. (2020). Endocrine disruption and obesity: A current review on environmental obesogens. Current Research in Green and Sustainable Chemistry, 3, 100 – 002. https://doi.org/10.1016/j.crgsc.2020.06.002
Heindel, J. J. (2019). History of the obesogen field: Looking back to look forward. Frontiers in Endocrinology, 10, 14. https://doi.org/10.3389/fendo.2019.00014
Heindel, J. J., Lustig, R. H., Howard, S., & Corkey, B. E. (2024). Obesogens: A unifying theory for the global rise in obesity. International Journal of Obesity (London), 48(4), 449 – 460. https://doi.org/10.1038/s41366-024-01460-3
Janesick, A., & Blumberg, B. (2012). Obesogens, stem cells and the developmental programming of obesity. International Journal of Andrology, 35(3), 437 – 448. https://doi.org/10.1111/j.1365-2605.2012.01247.x
Jaskulak, M., Zimowska, M., Rolbiecka, M., & Zorena, K. (2025). Understanding the role of endocrine disrupting chemicals as environmental obesogens in the obesity epidemic: A comprehensive overview of epidemiological studies between 2014 and 2024. Ecotoxicology and Environmental Safety, 299, 118401. https://doi.org/10.1016/j.ecoenv.2025.118401
Kannan, K., & Vimalkumar, K. (2021). A review of human exposure to microplastics and insights into microplastics as obesogens. Frontiers in Endocrinology, 12, Article 724989. https://doi.org/10.3389/fendo.2021.724989
Kapama, A., Stefanaki, C., Mastorakos, G., & Papagianni, M. (2025). The role of endocrine disruptors in childhood obesity: Unraveling the obesogens. Hormone Research in Paediatrics, 26, 1 – 14. https://doi.org/10.1159/000545043
Kladnicka, I., Bludovska, M., Plavinova, I., Muller, L., & Mullerova, D. (2022). Obesogens in foods. Biomolecules, 12(5), 680. https://doi.org/10.3390/biom12050680
Lee, M. K., & Blumberg, B. (2019). Transgenerational effects of obesogens. Basic & Clinical Pharmacology & Toxicology, 125(S3), 44 – 57. https://doi.org/10.1111/bcpt.13214
Lewis, N., Abdulkadir, A., Kandel, S., Rosby, R., & Hossain, E. (2024). Per- and polyfluoroalkyl substances (PFAS) as emerging obesogens: Mechanisms, epidemiological evidence, and regulatory challenges. Physiologia, 4(4), 517 – 567. https://doi.org/10.3390/physiologia4040035
Li, X., Ycaza, J., & Blumberg, B. (2011). The environmental obesogen tributyltin chloride acts via peroxisome proliferator-activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. Journal of Steroid Biochemistry and Molecular Biology, 127(1 – 2), 9 – 15. https://doi.org/10.1016/j.jsbmb.2011.03.012
Martinez-Esquivel, A., Trujillo-Silva, J. D., & Cilia-Lopez, G. V. (2022). Impact of environmental pollution on the obesogenic environment. Nutrition Reviews, 80(7), 1787 – 1799. https://doi.org/10.1093/nutrit/nuac003
Micić, D., Polovina, S., Micić, D., & Macut, D. (2021). Endocrine disrupting chemicals and obesity: The evolving story of obesogens. Acta Endocrinologica (Bucharest), 17(4), 503 – 508. https://doi.org/10.4183/aeb.2021.503
Mohajer, N., Du, C. Y., Checkcinco, C., & Blumberg, B. (2021). Obesogens: How they are identified and molecular mechanisms underlying their action. Frontiers in Endocrinology, 12, 780888. https://doi.org/10.3389/fendo.2021.780888
Nicolaou, M., Toumba, M., Kythreotis, A., Daher, H., & Skordis, N. (2024). Obesogens in adolescence: Challenging aspects and prevention strategies. Children, 11(5), 602. https://doi.org/10.3390/children11050602
Núñez-Sánchez, A. M., Jiménez-Méndez, A., Suárez-Cortés, M., Martínez-Sánchez, A. M., Sánchez-Solís, M., Blanco-Carnero, E. J., Ruiz-Alcaraz, J. A., & Ramos-Molina, B. (2023). Inherited epigenetic hallmarks of childhood obesity derived from prenatal exposure to obesogens. International Journal of Environmental Research and Public Health, 20(6), 4711. https://doi.org/10.3390/ijerph20064711
Oliviero, F., Marmugi, A., Viguié, C., Gayrard, V., Picard-Hagen, N., & Mselli-Lakhal, L. (2022). Are BPA substitutes as obesogenic as BPA? International Journal of Molecular Sciences, 23(8), 4238. https://doi.org/10.3390/ijms23084238
Piché, M. E., Tchernof, A., & Després, J. P. (2020). Obesity phenotypes, diabetes, and cardiovascular diseases. Circulation Research, 126(11), 1477 – 1500. https://doi.org/10.1161/CIRCRESAHA.120.316101
Rato, L., & Sousa, A. C. A. (2021). The impact of endocrine-disrupting chemicals in male fertility: Focus on the action of obesogens. Journal of Xenobiotics, 11(4), 163 – 196. https://doi.org/10.3390/jox11040012
Ravichandran, G., Lakshmanan, D. K., Arunachalam, A., & Thilagar, S. (2022). Food obesogens as emerging metabolic disruptors: A toxicological insight. Journal of Steroid Biochemistry and Molecular Biology, 217, 106042. https://doi.org/10.1016/j.jsbmb.2021.106042
Shahnazaryan, U., Wójcik, M., Bednarczuk, T., & Kuryłowicz, A. (2019). Role of obesogens in the pathogenesis of obesity. Medicina, 55(9), 515. https://doi.org/10.3390/medicina55090515
Sousa, A. C. A., Alves, M. G., Oliveira, P. F., Silva, B. M., & Rato, L. (2022). Male infertility in the XXI century: Are obesogens to blame? International Journal of Molecular Sciences, 23(6), 3046. https://doi.org/10.3390/ijms23063046
Urbanetz, L. A. M. L., Soares Junior, J. M., Maciel, G. A. R., Simões, R. S., Baracat, M. C. P., & Baracat, E. C. (2023). Does bisphenol A (BPA) participate in the pathogenesis of polycystic ovary syndrome (PCOS)? Clinics, 78, 100310. https://doi.org/10.1016/j.clinsp.2023.100310
Veiga-Lopez, A., Pu, Y., Gingrich, J., & Padmanabhan, V. (2018). Obesogenic endocrine-disrupting chemicals: Identifying knowledge gaps. Trends in Endocrinology & Metabolism, 29, 607 – 625. https://doi.org/10.1016/j.tem.2018.06.003
Wang, X., Sun, Z., Liu, Q. S., Zhou, Q., & Jiang, G. (2024). Environmental obesogens and their perturbations in lipid metabolism. Environment & Health, 2(5), 253 – 268. https://doi.org/10.1021/envhealth.3c00202
Wu, S., Tong, C., & Liu, J. (2025). Obesogenic effects of six classes of emerging contaminants. Journal of Environmental Sciences, 151, 252 – 272. https://doi.org/10.1016/j.jes.2024.03.032
Yilmaz, B., Erdogan, C. S., Sandald, S., Kelestimur, F., & Carpenter, D. O. (2025). Obesogens and energy homeostasis: Definition, mechanisms of action, exposure, and adverse effects on human health. Neuroendocrinology, 115, 72 – 99. https://doi.org/10.1159/000542901
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.
Prawa autorskie (c) 2025 Kwartalnik Naukowy Fides et Ratio